Fri, Aug 22, 2014, 3:52 AM EDT - U.S. Markets open in 5 hrs 38 mins


% | $
Quotes you view appear here for quick access.

Pfizer Inc. Message Board

  • fizrwinnr11 fizrwinnr11 May 16, 2012 12:17 AM Flag

    From Value Line's post-earnings Supplemental Report

    All told, our investment thesis remains largely unchanged from our April 13th report and we are maintaining our 2012 earnings estimate of $1.25 a share.

    Pfizer is a strong company with solid fundamentals and sizable shares in most markets. Although patent expirations are a concern, we believe the drugmaker should be able to effectively weather the storm given its impressive track record.

    With several pipeline products showing promise in late-stage studies, we believe it is only a matter of time before these drugs are developed into meaningful top-line contributors. For investors seeking a strong total-return play with relative stability, neutrally-ranked Pfizer stock has an above-average dividendyield and a top rank for safety. The company's financial strength (A+) is also outstanding.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Value line seldom has better than a Neutral rating on Pfizer largely because it insists on using GAAP accounting (notice the $1.25 forecast that it is using).

      Pfizer is the ONLY big, domestic pharma where Value Line uses GAAP - for MRK which last year only reported a few dimes per share in GAAP earnings, Value Line shows the non-GAAP figure of $3.77. Moreover, Value Line shows GAAP results and estimates for Pfizer only for the years 2008 and thereafter; all stats through 2007 are non-GAAP.

      On occasions I've been sorely tempted to cancel my subscription with them but I just can't afford to not be without their 15-year history of revenues, stock price ranges and in most cases non-GAAP earnings.

      However, the commentary and PE multiples are most unfair when Value Line uses GAAP for Pfizer and non-GAAP for everyone else.

28.82-0.07(-0.24%)Aug 21 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.